A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes (AMPLIFY-1)

October 30, 2026 updated by: Eli Lilly and Company

A Phase 3 Study to Investigate the Efficacy and Safety of LY900043 in Adult Participants With Obesity Without Type 2 Diabetes

The purpose of this study is to investigate the efficacy and safety of eloralintide and tirzepatide coformulation (EloraTZP) compared with tirzepatide, eloralintide and placebo for body weight reduction in participants with obesity.

Participation in the study will last about 2 years.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

2115

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
  • Phone Number: 317-615-4559
  • Email: LillyTrials@Lilly.com

Study Locations

      • Bahía Blanca, Argentina, 8000
        • Instituto de Investigaciones Clínicas Bahia Blanca
        • Contact:
          • Phone Number: 54 9291 4529990
        • Principal Investigator:
          • Daniel Vogel
      • Buenos Aires, Argentina, C1407GTN
        • CEMEDIC
        • Principal Investigator:
          • Olga Paez
      • Buenos Aires, Argentina, C1425AGC
        • Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
        • Principal Investigator:
          • Antonela Mainardi
        • Contact:
          • Phone Number: 01148019001
      • Buenos Aires, Argentina, 1426
        • Consultorio Medico Investigador Principal Dr Besada
        • Contact:
          • Phone Number: 4896-1734
        • Principal Investigator:
          • Diego Besada
      • Buenos Aires, Argentina, 1424
        • Cicemo Srl
        • Contact:
          • Phone Number: 541160410129
        • Principal Investigator:
          • Alejandro de Dios
      • Buenos Aires, Argentina, C1128AAF
        • Mautalen Salud e Investigación
        • Contact:
          • Phone Number: 541145143400
        • Principal Investigator:
          • Jose Fretes
      • Buenos Aires, Argentina, C1120AAC
        • Centro Médico Viamonte
        • Principal Investigator:
          • Diego Aizenberg
        • Contact:
          • Phone Number: 54 1149635650
      • Buenos Aires, Argentina, 1045
        • DOLZ Investigación Clínica
        • Principal Investigator:
          • Mariano Dolz
      • Ciudad de Buenos Aires, Argentina, C1012AAR
        • IDIM - Instituto de Investigaciones Metabólicas
        • Principal Investigator:
          • Maria Zanchetta
      • Córdoba, Argentina, 5006
        • Centro Medico Privado San Vicente Diabetes
        • Contact:
          • Phone Number: 03514584801
        • Principal Investigator:
          • Mariana Peralta
      • Del Viso, Argentina, 1669
        • MICA - Medicina e Investigación Cardiometabólica
        • Principal Investigator:
          • Micaela Mirada
        • Contact:
          • Phone Number: 54 11 3845-9542
      • Godoy Cruz, Argentina, 5501
        • Hospital Español de Mendoza
        • Contact:
          • Phone Number: +54 9 2614727364
        • Principal Investigator:
          • Matias Arrupe
      • Granadero Baigorria, Argentina, 2152
        • Centro de Investigaciones Clínicas Baigorria
        • Principal Investigator:
          • Juan Dominguez
        • Contact:
          • Phone Number: 5493412106243
      • Junín, Argentina, 6000
        • CMD-Centro Médico y Diagnóstico por Imágenes
        • Contact:
          • Phone Number: 2364683120
        • Principal Investigator:
          • Maria Pelagagge
      • Mar del Plata, Argentina, 7600
        • Centro de Investigaciones Médicas Mar del Plata
        • Principal Investigator:
          • Andres Alvarisqueta
        • Contact:
          • Phone Number: 542234917628
      • Mendoza, Argentina, 5500
        • Instituto de Cardiología Wolff
        • Contact:
          • Phone Number: 5492615636018
        • Principal Investigator:
          • SEBASTIAN WOLFF
      • Rosario, Argentina, 2000
        • Instituto Médico Fundación Grupo Colaborativo Rosario Investigación y Prevención Medica
        • Contact:
          • Phone Number: 543416928531
        • Principal Investigator:
          • Horacio Sessa
      • Rosario, Argentina, 2000
        • Instituto Médico Catamarca IMEC
        • Contact:
          • Phone Number: 3416176661
        • Principal Investigator:
          • Natacha Maldonado
      • SAN M. de Tucuman, Argentina, T4000AXL
        • Centro de Investigaciones Médicas Tucuman
        • Contact:
          • Phone Number: 03814200180
        • Principal Investigator:
          • Magdalena Martinez Romero
      • Santiago del Estero, Argentina, 4200
        • Sanatorio Norte
        • Contact:
          • Phone Number: 0384154125573
        • Principal Investigator:
          • Franklin Abalos
      • Beijing, China, 100034
        • Peking University First Hospital
        • Principal Investigator:
          • Ying Gao
      • Beijing, China, 100034
        • Peking University People's Hospital
        • Contact:
          • Phone Number: 13910978815
        • Principal Investigator:
          • Linong Ji
      • Beijing, China, 100000
        • Luhe Hospital
        • Principal Investigator:
          • Dong Zhao
      • Changchun, China, 130041
        • The Second Hospital of Jilin University
        • Principal Investigator:
          • Hanqing Cai
      • Changsha, China, 410013
        • The Third Xiangya Hospital of Central South University
        • Principal Investigator:
          • Ping Jin
      • Chengdu, China, 610072
        • Sichuan Provincial People's Hospital
        • Principal Investigator:
          • Limin Tian
      • Chongqing, China, 400000
        • 2nd Affiliated Hospital Chongqing Medical Universi
        • Principal Investigator:
          • Dongfang Liu
        • Contact:
          • Phone Number: 13594028475
      • Guangzhou, China, 510630
        • The First Affiliated Hospital of Jinan University
        • Principal Investigator:
          • jingge yang
      • Guangzhou, China, 510280
        • Zhujiang Hospital
        • Principal Investigator:
          • Jia Sun
      • Hefei, China, 230011
        • The Second People's Hospital of Hefei
        • Principal Investigator:
          • Jun Ye
        • Contact:
          • Phone Number: 86-13956099720
      • Jinan, China, 250013
        • Jinan Central Hospital
        • Principal Investigator:
          • Nianrong Mi
      • Luoyang, China, 471000
        • The First Affiliated Hospital of Henan University of Science &Technology
        • Principal Investigator:
          • Hongwei Jiang
        • Contact:
          • Phone Number: 13653880139
      • Luzhou, China, 646000
        • Affiliated Hospital of Luzhou Medical College
        • Principal Investigator:
          • Qin Wan
      • Nanchang, China, 330038
        • Jiangxi Provincial People's Hospital
        • Principal Investigator:
          • Zongyou Cheng
        • Contact:
          • Phone Number: 13767035719
      • Nanjing, China, 210006
        • Nanjing First Hospital
        • Principal Investigator:
          • Qian Li
      • Nanjing, China, 210011
        • The Second Affiliated Hospital of Nanjing Medical University
        • Principal Investigator:
          • Yibing Lu
        • Contact:
          • Phone Number: 18951762960
      • Nanjing, China, 211100
        • Nanjing Medical University - Nanjing Jiangning Hospital
        • Principal Investigator:
          • Kun Wang
        • Contact:
          • Phone Number: 025-52105625
      • Nanjing, China, 210008
        • Jiangsu Province Official Hospital
        • Principal Investigator:
          • Wei Tang
      • Nanyang, China, 473007
        • The First Affiliated Hospital of Nanyang Medical College
        • Contact:
          • Phone Number: 13837739967
        • Principal Investigator:
          • Dexue Liu
      • Ningbo, China, 315010
        • Ningbo First Hospital
        • Contact:
          • Phone Number: 13757426626
        • Principal Investigator:
          • Li Li
      • Qinhuangdao Shi, China, 066000
        • The First Hospital of Qinhuangdao
        • Principal Investigator:
          • Bowei Liu
        • Contact:
          • Phone Number: 15903366689
      • Shanghai, China, 201800
        • Jiading District Central Hospital
        • Principal Investigator:
          • Lixia Suo
      • Shijiazhuang, China, 050031
        • The First Hospital of Hebei Medical University
        • Principal Investigator:
          • Huijuan Ma
      • Suzhou, China, 215006
        • The First Affiliated Hospital of Soochow University
        • Principal Investigator:
          • Bimin Shi
      • Xianyang, China, 712000
        • Xianyang Hospital of Yan'an University
        • Principal Investigator:
          • Fang Wang
        • Contact:
          • Phone Number: 18391081568
      • Berlin, Germany, 10629
        • FutureMeds Berlin
        • Principal Investigator:
          • Peter Hahn
        • Contact:
          • Phone Number: +49 30 439741 239
      • Bochum, Germany, 44787
        • Siteworks GmbH - Bochum
        • Contact:
          • Phone Number: +49 234 60144350
        • Principal Investigator:
          • Annemone Koechel
      • Cologne, Germany, 51069
        • Zentrum fur klinische Forschung - Köln
        • Principal Investigator:
          • Bastian Kirsch
        • Contact:
          • Phone Number: 00492212972813
      • Essen, Germany, 45136
        • InnoDiab Forschung Gmbh
        • Principal Investigator:
          • Gundega Sipola
      • Gladbeck, Germany, 45968
        • Hausarztzentrum Butendorf
        • Contact:
          • Phone Number: 0049204329460
        • Principal Investigator:
          • Zuhal Kundakci
      • Hamburg, Germany, 22607
        • Diabeteszentrum Hamburg West
        • Contact:
          • Phone Number: 4940896295
        • Principal Investigator:
          • Dominik Dahl
      • Leipzig, Germany, 04107
        • AmBeNet GmbH
        • Contact:
          • Phone Number: 4934196276326
        • Principal Investigator:
          • Hans-Detlev Stahl
      • Lübeck, Germany, 23538
        • UKSH Campus Lübeck, Med. 1 - AG Meyhöfer
        • Principal Investigator:
          • Svenja Meyhöfer
        • Contact:
          • Phone Number: 49451 50075673
      • Offenbach, Germany, 63065
        • FutureMeds Offenbach
        • Principal Investigator:
          • Christel Contzen
        • Contact:
          • Phone Number: 0049 69 247433849
      • Oldenburg, Germany, 23758
        • RED-Institut GmbH
        • Principal Investigator:
          • Thomas Schaum
        • Contact:
          • Phone Number: 0049436150630128
      • Ratingen, Germany, 40882
        • Sanos Clinic
        • Principal Investigator:
          • Jens Harmel
        • Contact:
          • Phone Number: 021025643873
      • Ahmedabad, India, 380013
        • Avron Hospitals
        • Principal Investigator:
          • Tiven Marwah
        • Contact:
          • Phone Number: 079 66 200480
      • Baroda, India, 390021
        • GMERS Medical College and General Hospital
        • Principal Investigator:
          • Varsha Godbole
      • Belagavi, India, 59006
        • CentraCare Super Speciality Hospital and Medical Research Centre
        • Principal Investigator:
          • Neeta Deshpande
      • Chennai, India, 600003
        • Rajiv Gandhi Government General Hospital
        • Principal Investigator:
          • Dr. Ranjith Pratap Shanmugam
      • Guntur, India, 522001
        • Endolife Speciality Hospitals
        • Principal Investigator:
          • Kongara Srikanth
        • Contact:
          • Phone Number: 9849945577
      • Hubli, India, 580021
        • Karnataka Institute of Medical Sciences
        • Principal Investigator:
          • RAM KAULGUD
      • Kanpur, India, 208011
        • Atmaram Child Care
        • Principal Investigator:
          • Manish Singh
      • Noida, India, 201306
        • Yatharth Super Speciality Hospital - Noida Extension
        • Principal Investigator:
          • Nishant Singh
      • Pune, India, 411057
        • Lifepoint Multispeciality Hospital
        • Principal Investigator:
          • Sachin Shivnitwar
      • Raipur, India, 492099
        • All India Institute of Medical Sciences
        • Principal Investigator:
          • Pankaj Kannauje
      • Udaipur, India, 313001
        • Pacific Medical College & Hospital
        • Principal Investigator:
          • Nilesh Patira
      • Vellore, India, 632004
        • Christian Medical College Vellore
        • Principal Investigator:
          • Nitin Kapoor
      • Chiyoda City, Japan, 102-0084
        • Yotsuya Medical Cube
        • Contact:
          • Phone Number: 81120023812
        • Principal Investigator:
          • Akio Kanazawa
      • Chūōku, Japan, 103-0027
        • Medical Corporation Chiseikai Tokyo Center Clinic
        • Contact:
          • Phone Number: 81120023812
        • Principal Investigator:
          • Hirotaka Nagashima
      • Chūōku, Japan, 104-0031
        • Tokyo Asbo Clinic
        • Principal Investigator:
          • Akiyoshi Uchiyama
        • Contact:
          • Phone Number: 81120023812
      • Chūōku, Japan, 103-0025
        • Nihonbashi Sakura Clinic
        • Contact:
          • Phone Number: 81120023812
        • Principal Investigator:
          • Kumie Ito
      • Kawasaki, Japan, 213-0001
        • Mizonokuchi Okamoto Clinic
        • Contact:
          • Phone Number: 81120023812
        • Principal Investigator:
          • Yoshihisa Okamoto
      • Kin-cho, Kunigami-gun, Japan, 904-1201
        • aSBo Medical Clinic
        • Contact:
          • Phone Number: 81120023812
        • Principal Investigator:
          • HIDEKI RYO
      • Nerima-ku, Japan, 177-0051
        • Shimamura Memorial Hospital
        • Contact:
          • Phone Number: 81120023812
        • Principal Investigator:
          • Tatsuto Mizuno
      • Shinjuku, Japan, 160-0023
        • MY Medical Clinic - Shinjuku
        • Contact:
          • Phone Number: 81120023812
        • Principal Investigator:
          • YOSHIHIKO CHONO
      • Shinjuku-ku, Japan, 160-0004
        • Clinical Research Hospital Tokyo
        • Contact:
          • Phone Number: 81120023812
        • Principal Investigator:
          • Hiroyuki Fukase
      • Urasoe, Japan, 901-2102
        • Urasoe General Hospital
        • Contact:
          • Phone Number: 81120023812
        • Principal Investigator:
          • Toshiya Chinen
      • Ponce, Puerto Rico, 00717
        • Puerto Rico Medical Research
        • Principal Investigator:
          • Jose Santiago
        • Contact:
          • Phone Number: 787-284-5366
      • San Juan, Puerto Rico, 00918
        • CMRC Headlands, LLC
        • Principal Investigator:
          • Jorge Bustillo
      • San Juan, Puerto Rico, 00921
        • Miralles Clinical Research
        • Contact:
          • Phone Number: 787-226-1014
        • Principal Investigator:
          • Eduardo Miralles-Alonso
      • Ansan-si, South Korea, 15355
        • Korea University Ansan Hospital
        • Contact:
          • Phone Number: 82314124274
        • Principal Investigator:
          • NANHEE KIM
      • Busan, South Korea, 50612
        • Pusan National University Yangsan Hospital
        • Principal Investigator:
          • Sang Yeoup Lee
        • Contact:
          • Phone Number: 82-55-360-2860
      • Guri-si, South Korea, 11923
        • Hanyang University Guri Hospital
        • Principal Investigator:
          • Sangmo Hong
      • Gwangju, South Korea, 61453
        • Chosun University Hospital
        • Principal Investigator:
          • Sang Yong Kim
      • Gyeongsan-si, South Korea, 42415
        • Yeungnam Univeristy Medical Center
        • Principal Investigator:
          • KYUCHANG WON
        • Contact:
          • Phone Number: 82-10-9370-3846
      • Junggu, South Korea, 41944
        • Kyungpook National University Hospital
        • Principal Investigator:
          • Hae-Jin Ko
      • Namdong-gu, South Korea, 21565
        • Gachon University Gil Medical Center
        • Principal Investigator:
          • Kyoung-Kon Kim
        • Contact:
          • Phone Number: +82-32-458-2778
      • Seogu, South Korea, 35365
        • Konyang University Hospital
        • Principal Investigator:
          • Jee Hyun Kang
      • Seongnam, South Korea, 13620
        • Seoul National University Bundang Hospital
        • Principal Investigator:
          • Kiheon Lee
      • Seongnam-si, South Korea, 13496
        • CHA Bundang Medical Center, CHA University
        • Principal Investigator:
          • Young-Sang Kim
      • Seoul, South Korea, 03080
        • Seoul National University Hospital
        • Principal Investigator:
          • BeLong Cho
      • Seoul, South Korea, 01830
        • Nowon Eulji Medical Center, Eulji University
        • Principal Investigator:
          • kyungwan Min
        • Contact:
          • Phone Number: 1093908214
      • Seoul, South Korea, 03722
        • Severance Hospital, Yonsei University Health System
        • Principal Investigator:
          • Byung Wan Lee
      • Blackpool, United Kingdom, FY3 7EN
        • Layton Medical Centre
        • Contact:
          • Phone Number: 441253951943
        • Principal Investigator:
          • Rebecca Clark
      • Lancashire, United Kingdom, OL6 6EW
        • Ashton Medical Group - Chapel House
        • Principal Investigator:
          • Omair Razzaq
      • London, United Kingdom, EC2Y 8EA
        • St Pancras Clinical Research
        • Principal Investigator:
          • Sandra Bonsu
      • Penzance, United Kingdom, TR18 3DX
        • Atlantic Medical
        • Principal Investigator:
          • Alex Dewdney
      • Romsey, United Kingdom, SO51 7QN
        • Abbeywell Surgery
        • Principal Investigator:
          • Nicola Lester
        • Contact:
          • Phone Number: 01794 512218
      • West Kirby, United Kingdom, CH48 5AA
        • Marine Lake Medical Practice
        • Principal Investigator:
          • James Perry
    • Arizona
      • Mesa, Arizona, United States, 85206
        • Care Access - 801 South Power Road, Mesa
        • Principal Investigator:
          • Michael Waters
        • Contact:
          • Phone Number: 877-791-0656
      • Scottsdale, Arizona, United States, 85260
        • Headlands Research - Scottsdale
        • Contact:
          • Phone Number: 480-725-8708
        • Principal Investigator:
          • Benjamin Clark
      • Tucson, Arizona, United States, 85712
        • Tucson Clinical Research Institute
        • Principal Investigator:
          • Girish Karamchandani
    • California
      • Covina, California, United States, 91723
        • Valley Clinical Trials, Inc.
        • Contact:
          • Phone Number: 310-309-9491
        • Principal Investigator:
          • Linda Glaser
      • Los Angeles, California, United States, 90015
        • Los Angeles Institute for Metabolic Research
        • Contact:
          • Phone Number: 213-373-8380
        • Principal Investigator:
          • Juan Frias
      • Rolling Hills Estates, California, United States, 90274
        • Peninsula Research Associates
        • Principal Investigator:
          • Lawrence Sher
        • Contact:
          • Phone Number: 3102651623
      • San Diego, California, United States, 92123
        • Artemis Institute for Clinical Research
        • Contact:
          • Phone Number: 858-278-3647
        • Principal Investigator:
          • Stacey Layle
      • Santa Ana, California, United States, 92701
        • Southern California Clinical Research
        • Principal Investigator:
          • Wayne Ho
        • Contact:
          • Phone Number: 7144742173
    • Connecticut
      • New Haven, Connecticut, United States, 06519
        • Yale University School of Medicine
        • Principal Investigator:
          • Ania Jastreboff
        • Contact:
          • Phone Number: (203) 785-7421
    • Florida
      • Atlantis, Florida, United States, 33462
        • JEM Research Institute
        • Principal Investigator:
          • David Halpert
        • Contact:
          • Phone Number: 5619682933
      • Maitland, Florida, United States, 32751
        • K2 Medical Research - Maitland
        • Contact:
          • Phone Number: 407-810-2790
        • Principal Investigator:
          • Neel Patel
      • Miami, Florida, United States, 33135
        • Flourish Research - Miami, LLC
        • Contact:
          • Phone Number: 305-631-6704
        • Principal Investigator:
          • Mark Rosenthal
      • Tamarac, Florida, United States, 33321
        • Care Access - Tamarac
        • Principal Investigator:
          • Brad Lipson
        • Contact:
          • Phone Number: 877-791-0656
      • Tampa, Florida, United States, 33625
        • Care Access - Tampa
        • Principal Investigator:
          • Shital Mehta
        • Contact:
          • Phone Number: 813-771-5980
    • Georgia
      • Dalton, Georgia, United States, 30720
        • Care Access - Dalton Walmart
        • Contact:
          • Phone Number: 877-791-0656
        • Principal Investigator:
          • Chukwukanene Ofiaeli
      • Dunwoody, Georgia, United States, 30338
        • Teak Research Consults - Dunwoody
        • Principal Investigator:
          • Aakar Thaker
        • Contact:
          • Phone Number: 4704034755
      • Stockbridge, Georgia, United States, 30281
        • Clinical Research Atlanta
        • Contact:
          • Phone Number: 770-507-6867
        • Principal Investigator:
          • Jason Agran
      • Union City, Georgia, United States, 30291
        • Rophe Adult and Pediatric Medicine/SKYCRNG
        • Principal Investigator:
          • Dwight Blake
        • Contact:
          • Phone Number: 470-317-3604
    • Hawaii
      • Honolulu, Hawaii, United States, 96814
        • East-West Medical Research Institute
        • Contact:
          • Phone Number: 8085316886
        • Principal Investigator:
          • Cindy Pau
    • Illinois
      • Chicago, Illinois, United States, 60641
        • IMA Clinical Research Chicago
        • Principal Investigator:
          • Nadijda Bassil
    • Indiana
      • Indianapolis, Indiana, United States, 46254
        • DM Clinical Research - Indianapolis
        • Principal Investigator:
          • Brandon Essink
        • Contact:
          • Phone Number: 463-271-3050
    • Louisiana
      • Eunice, Louisiana, United States, 70535
        • Care Access - Eunice
        • Principal Investigator:
          • Randall Miller
        • Contact:
          • Phone Number: 3374578841
      • Metairie, Louisiana, United States, 70006
        • Clinical Trials Management, LLC d/b/a Flourish Research
        • Principal Investigator:
          • David Dulitz
        • Contact:
          • Phone Number: 5044551310
    • Maryland
      • Baltimore, Maryland, United States, 21208
        • Pharmasite Research, Inc.
        • Principal Investigator:
          • Sarah Herts
        • Contact:
          • Phone Number: 410 602-1440
      • Baltimore, Maryland, United States, 21213
        • Care Access - Baltimore
        • Principal Investigator:
          • Peta-Gay Jackson Booth
        • Contact:
          • Phone Number: 877-791-0656
    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Brigham and Women's Hospital Diabetes Program
        • Principal Investigator:
          • Vanita Aroda
        • Contact:
          • Phone Number: 6177324245
    • Mississippi
      • Ridgeland, Mississippi, United States, 39157
        • SKY Integrative Medical Center/SKYCRNG
        • Principal Investigator:
          • Bob Hutchins
        • Contact:
          • Phone Number: 601-567-1321
    • Nevada
      • Las Vegas, Nevada, United States, 89148
        • Palm Research Center Sunset
        • Principal Investigator:
          • Ellen Neylon
      • Las Vegas, Nevada, United States, 89102
        • IMA Clinical Research Las Vegas
        • Contact:
          • Phone Number: 702-463-8888
        • Principal Investigator:
          • Nasim Amjadi
    • New Mexico
      • Albuquerque, New Mexico, United States, 87109
        • IMA Clinical Research Albuquerque
        • Contact:
          • Phone Number: 5058483773
        • Principal Investigator:
          • Shenif Ladak
    • New York
      • Long Island City, New York, United States, 11106
        • NYC Research INC
        • Principal Investigator:
          • Anastasios Manessis
        • Contact:
          • Phone Number: 516-574-9232
      • New York, New York, United States, 10021
        • Weill Cornell Medical College
        • Principal Investigator:
          • Alpana Shukla
        • Contact:
          • Phone Number: 646-962-2424
      • New York, New York, United States, 10036
        • IMA Clinical Research NYC Midtown
        • Principal Investigator:
          • Eli Shalenberg
    • North Carolina
      • Chapel Hill, North Carolina, United States, 27514
        • University of North Carolina Medical Center
        • Principal Investigator:
          • Klara Klein
        • Contact:
          • Phone Number: 9849743004
      • Greensboro, North Carolina, United States, 27401
        • Medication Management
        • Contact:
          • Phone Number: 3367636968
        • Principal Investigator:
          • James Franklin
      • Raleigh, North Carolina, United States, 27607
        • Care Access - Raleigh
        • Principal Investigator:
          • Chandar Abboy
        • Contact:
          • Phone Number: 877-791-0656
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19114
        • Clinical Research of Philadelphia
        • Contact:
          • Phone Number: 215-676-6696
        • Principal Investigator:
          • JOSEPH HEETHER
      • Plymouth Meeting, Pennsylvania, United States, 19462
        • Keystone Clinical Studies
        • Principal Investigator:
          • Cameron Olezene
    • Tennessee
      • Memphis, Tennessee, United States, 38119
        • Clinical Neuroscience Solutions Inc.
        • Contact:
          • Phone Number: 9018431045
        • Principal Investigator:
          • Lisa Usdan
    • Texas
      • Bellaire, Texas, United States, 77401
        • The University of Texas Health Science Center at Houston
        • Contact:
          • Phone Number: 713-486-1350
        • Principal Investigator:
          • Deborah Horn
      • Bellaire, Texas, United States, 77401
        • JCCT - Juno Bellaire Site
        • Contact:
          • Phone Number: 713-779-5494
        • Principal Investigator:
          • Rocio Harbison
      • Dallas, Texas, United States, 75251
        • Cedar Health Research
        • Contact:
          • Phone Number: 214-253-8170
        • Principal Investigator:
          • Sefanit Gebretsadik
      • Euless, Texas, United States, 76040
        • Cedar Health Research - Euless
        • Principal Investigator:
          • Debbie Bridges
        • Contact:
          • Phone Number: 2142538170
      • Houston, Texas, United States, 77043
        • Biopharma Informatic, LLC
        • Contact:
          • Phone Number: 281-944-3610
        • Principal Investigator:
          • Agadadash Kuliev
      • Houston, Texas, United States, 77082
        • Care Access - Houston - Clinical Trials Center by Walmart & Care Access
        • Principal Investigator:
          • Ali Bajwa
        • Contact:
          • Phone Number: 877-791-0656
      • Houston, Texas, United States, 77079
        • PlanIt Research, LLC
        • Contact:
          • Phone Number: 713-973-3415
        • Principal Investigator:
          • Christina Michaelis
      • Kingwood, Texas, United States, 77339
        • Activian Clinical Research
        • Principal Investigator:
          • Martin Basaldua
        • Contact:
          • Phone Number: 832 969 3401
      • San Antonio, Texas, United States, 78229
        • Clinical Trials of Texas, LLC
        • Contact:
          • Phone Number: 210-949-0122
        • Principal Investigator:
          • Douglas Denham
      • Shavano Park, Texas, United States, 78231
        • Consano Clinical Research, LLC
        • Contact:
          • Phone Number: 210-545-4900
        • Principal Investigator:
          • Michelle Welch
      • Tyler, Texas, United States, 75704
        • Care Access - Tyler - Clinical Trials Center by Walmart & Care Access
        • Contact:
          • Phone Number: 877-791-0656
        • Principal Investigator:
          • Alphonse Ekole
    • Utah
      • West Valley City, Utah, United States, 84120
        • Kalo Clinical Research
        • Principal Investigator:
          • Joshua Alam
    • Virginia
      • Arlington, Virginia, United States, 22206
        • Care Access - Arlington 2
        • Contact:
          • Phone Number: 877-791-0656
        • Principal Investigator:
          • Chih Chao Yang
      • Arlington, Virginia, United States, 22206
        • Washington Center for Weight Management and Research
        • Contact:
          • Phone Number: 7038070037
        • Principal Investigator:
          • Domenica Rubino
      • Newport News, Virginia, United States, 23606
        • Health Research of Hampton Roads, Inc.
        • Contact:
          • Phone Number: 757-591-8100
        • Principal Investigator:
          • George Freeman
      • Norfolk, Virginia, United States, 23510
        • Eastern Virginia Medical School (EVMS) Medical Group
        • Principal Investigator:
          • Elias Siraj
        • Contact:
          • Phone Number: 757-446-5291

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Have a stable self-reported body weight (<5% body weight change) for 90 days prior to screening
  • Have a BMI of ≥35 kg/m2 at screening
  • Have a history of at least 1 self-reported unsuccessful dietary effort to reduce body weight

Exclusion Criteria:

  • Have a prior or planned surgical treatment for obesity (liposuction, cryolipolysis, or abdominoplasty allowed if performed >1 year before screening)

  • Have a prior or planned endoscopic procedure and/or device-based therapy for obesity and/or type 2 diabetes (prior device-based therapy acceptable if device removal was more than 6 months prior to screening)

  • Have type 1 diabetes, type 2 diabetes, or any other type of diabetes

  • Have had within 90 days prior to screening:

    • heart attack
    • stroke
    • coronary artery revascularization
    • unstable angina, or
    • hospitalization due to congestive heart failure
  • Have a history or diagnosis of New York Heart Association Functional Classification Class IV congestive heart failure

  • Have taken any glucose-lowering medication within 90 days of screening

  • Have taken medications or alternative remedies intended for weight loss within 90 days of screening

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo

Participants will receive placebo SC

Administered SC

Experimental: Tirzepatide

Participants will receive tirzepatide SC

Administered SC

Other Names:
  • LY3298176
Experimental: EloraTZP Dose 1

Participants will receive EloraTZP subcutaneously (SC)

Administered SC

Other Names:
  • LY900043
Experimental: EloraTZP Dose 2

Participants will receive EloraTZP SC

Administered SC

Other Names:
  • LY900043
Experimental: EloraTZP Dose 3

Participants will receive EloraTZP SC

Administered SC

Other Names:
  • LY900043
Experimental: EloraTZP Dose 4

Participants will receive EloraTZP SC

Administered SC

Other Names:
  • LY900043
Experimental: EloraTZP Dose 5

Participants will receive EloraTZP SC

Administered SC

Other Names:
  • LY900043
Experimental: Eloralintide

Participants will receive eloralintide SC

Administered SC

Other Names:
  • LY3841136

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Percent Change from Baseline in Body Weight
Time Frame: Baseline, Week 100
Baseline, Week 100

Secondary Outcome Measures

Outcome Measure
Time Frame
Change from Baseline in Waist Circumference
Time Frame: Baseline, Week 100
Baseline, Week 100
Change from Baseline in Hemoglobin A1c (HbA1c)
Time Frame: Baseline, Week 100
Baseline, Week 100
Change from Baseline in Systolic Blood Pressure
Time Frame: Baseline, Week 100
Baseline, Week 100
Percent Change from Baseline in High-Sensitivity C-Reactive Protein (hsCRP)
Time Frame: Baseline, Week 100
Baseline, Week 100
Percent Change from Baseline in Total Body Fat Mass
Time Frame: Baseline, Week 100
Baseline, Week 100
Change from Baseline in Body Mass Index (BMI)
Time Frame: Baseline, Week 100
Baseline, Week 100
Percent Change from Baseline in Fasting Insulin
Time Frame: Baseline, Week 100
Baseline, Week 100
Change from Baseline in Estimated Glomerular Filtration Rate (eGFR)
Time Frame: Baseline, Week 100
Baseline, Week 100
Change from Baseline in EQ-5D-5L Score
Time Frame: Baseline, Week 100
Baseline, Week 100
Change from Baseline in Eating Behaviors and Attitudes Questionnaire (EBAQ) Score
Time Frame: Baseline, Week 100
Baseline, Week 100
Achievement of Improved Categorical Shift in Patient Global Impression of Severity (PGIS) Physical Function Weight
Time Frame: Baseline, Week 100
Baseline, Week 100
Overall Functional Assessment of Chronic Illness Therapy, Item GP5 (FACT-GP5) Score
Time Frame: Week 100
Week 100
Pharmacokinetics (PK): Maximum Concentration of Eloralintide at Steady State (Cmax,ss)
Time Frame: Baseline through Week 100
Baseline through Week 100
PK: Area Under the Concentration Versus Time Curve of Eloralintide for One Dosing Interval at Steady State (AUC(0-ᴛ)ss)
Time Frame: Baseline through Week 100
Baseline through Week 100
PK: Maximum Concentration of Tirzepatide at Steady State (Cmax,ss)
Time Frame: Baseline through Week 100
Baseline through Week 100
PK: Area Under the Concentration Versus Time Curve of Tirzepatide for One Dosing Interval at Steady State (AUC(0-ᴛ)ss)
Time Frame: Baseline through Week 100
Baseline through Week 100
Percent Change from Baseline in Triglycerides
Time Frame: Baseline, Week 100
Baseline, Week 100
Change from Baseline in Impact of Weight on Quality of Life-Lite Clinical Trials Version (IWQOL-Lite CT) Score
Time Frame: Baseline, Week 100
Baseline, Week 100
Percentage of Participants with a Change in Medication Use
Time Frame: Baseline through Week 100
Baseline through Week 100
Percentage of Participants who Develop Type 2 Diabetes
Time Frame: Baseline through Week 100
Baseline through Week 100

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2026

Primary Completion (Estimated)

October 1, 2029

Study Completion (Estimated)

November 1, 2029

Study Registration Dates

First Submitted

October 12, 2026

First Submitted That Met QC Criteria

October 12, 2026

First Posted (Actual)

October 19, 2026

Study Record Updates

Last Update Posted (Actual)

November 3, 2026

Last Update Submitted That Met QC Criteria

October 30, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.

IPD Sharing Time Frame

Data are available 6 months after the primary publication or approval of the indication studied in the US and EU, whichever is later. Data will be indefinitely available for requesting.

IPD Sharing Access Criteria

A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe